Elisa Bertocchi
Papers
1
Total Citations
14
H-Index
1
About
Elisa Bertocchi is a leading colorectal surgeon whose research focuses on optimizing surgical timing and minimally-invasive techniques for rectal cancer treatment. Her most impactful work centers on the critical question of when to operate after neoadjuvant chemoradiotherapy. As principal investigator of the landmark TiMiSNAR trial—a multicenter randomized controlled trial published in 2019—she demonstrated that extending the waiting period from the standard 8 weeks to 12 weeks before minimally-invasive surgery significantly increases pathologic complete response rates without compromising safety. This finding has direct implications for improving organ preservation strategies and patient outcomes. Her research has garnered over 14 citations for this pivotal study alone, establishing her as a key voice in rectal cancer management. Bertocchi’s work bridges the gap between oncologic efficacy and surgical precision, offering evidence-based guidance for clinicians worldwide. Her contributions are particularly notable for challenging long-held surgical conventions through rigorous trial design, making her a respected figure in the evolving landscape of colorectal oncology.
Research Focus
Key Achievements
Top Papers
- 1